Brief: Akili Says Received Letter From Nasdaq, Granted Compliance Period Until October 21, 2024
23/04/2024 22:41
April 23 (Reuters) - Akili Inc AKLI.O :
* AKILI - RECEIVED LETTER FROM NASDAQ, GRANTED COMPLIANCE
PERIOD
UNTIL OCTOBER 21, 2024 TO REGAIN COMPLIANCE WITH NASDAQ FOR
CONTINUED LISTING
Source text for Eikon: ID:n0001193125-24-107100
Further company coverage: AKLI.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Akili
See all newsBrief: Akili Announces FDA Authorization Of Endeavorotc, The First FDA Clearance Of A Digital Treatment For Adults With Adhd Through A Video Game
Brief: Virtual Therapeutics, Akili Interactive Enter Into Definitive Merger Agreement To Establish Leading Digital Health Company
Akili Inc reports results for the quarter ended in March - Earnings Summary
Akili Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Molson Coors, Starbucks, Warner Bros Discovery